Bonaid 150 mg (Tablet)
1 tablet kit: ৳ 1,500.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Ibandronic acid |
| Company | Labaid pharma ltd |
Indications
- Treatment of osteoporosis in women (specially postmenopausal)
- Prevention of osteoporosis in women (specially postmenopausal)
- Prevention and treatment of osteoporosis in men
Pharmacology
- Inhibition of bone resorption
- Prevents experimentally induced bone destruction
- Highly potent inhibitor of osteoclastic activity
- Reduces bone resorption with no direct effect on bone formation
Dosage & Administration
- Recommended dose of one 150 mg film-coated tablet once a month
- Tablet should be taken 60 minutes before the first food or drink of the day
- Tablet should be swallowed whole with a full glass of plain water
Interaction
- Interference with the absorption by calcium supplements and antacids
- No interaction potential with tamoxifen or hormone replacement therapy
- Increase in bioavailability when co-administered with ranitidine
Contraindications
- Known hypersensitivity to ibandronic acid or its excipients
- Uncorrected hypocalcemia
- Abnormalities of the esophagus delaying esophageal emptying
- Inability to stand or sit upright for at least 60 minutes
Side Effects
- Dyspepsia
- Nausea
- Diarrhea
- Abdominal pain
- Muscle aches
- Headaches
- Dizziness
Pregnancy & Lactation
- Not to be used during pregnancy
- No clinical experience in pregnant women
- Not to be used during lactation
Precautions & Warnings
- Treatment of hypocalcemia before starting therapy
- Caution in patients with active upper gastrointestinal problems
- Potential for severe esophageal adverse experiences
- Risk of osteonecrosis of the jaw
- Caution during concomitant medication with NSAIDs
Use in Special Populations
- No dosage adjustment for patients with mild or moderate renal impairment
- No dosage adjustment for patients with hepatic impairment
- No dosage adjustment for the elderly
- Safety and efficacy not established in patients less than 18 years old
Overdose Effects
- No specific information available on the treatment of overdosage
- Oral overdosage may result in upper gastrointestinal adverse events
Therapeutic Class
- Bisphosphonate preparations
Storage Conditions
- Keep below 30°C temperature
- Away from light & moisture
- Keep out of the reach of children